SRPT FY 2024 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.9B+53.0% YoY

Gross Profit

$1.6B83.2% margin

Operating Income

$218M11.5% margin

Net Income

$235M12.4% margin

EPS (Diluted)

$2.34

Cash Flow

Operating Cash Flow

-$206M

Free Cash Flow

-$353M

Stock-Based Comp.

$184M

Balance Sheet

Total Assets

$4.0B

Total Liabilities

$2.4B

Stockholders' Equity

$1.5B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.2B	+53.0%
Gross Profit	$1.6B	$1.1B	+44.8%
Operating Income	$218M	-$268M	+181.4%
Net Income	$235M	-$536M	+143.9%